Dr. Peter John Oppelt, MD

  • O'Fallon, IL
  • Medical oncologist
NPI1639332968PAC ID1052553112
Medicare services, 2024
48,339
Medicare patients, 2024
629
Part D claims, 2024
2,073
Publications
49
Clinical trials
10
Practice address
1404 Cross St, O'Fallon, IL 62269
Practice phone
Call (618) 257-5607
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Memorial Hospital - Shiloh

O'Fallon, Illinois

See all 11 affiliations

Find Dr. Oppelt's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Peter John Oppelt is a medical oncologist in O'Fallon, Illinois

Dr. Oppelt practices at Memorial Hospital - Shiloh in O'Fallon, Illinois.

Dr. Oppelt's NPI, 1639332968, was assigned on July 7, 2008. Dr. Oppelt graduated from University of Missouri, Columbia School of Medicine in 2008. Dr. Oppelt holds Missouri license 2015014057.

NPI and contact details
Medicare PAC ID
1052553112
NPI enumeration date
July 7, 2008
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(618) 257-5607
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
44
Medical school graduation
2008

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Peter John Oppelt practices at Memorial Hospital - Shiloh in O'Fallon, Illinois

Dr. Oppelt's primary practice is Memorial Hospital - Shiloh, at 1404 Cross St, O'Fallon, IL 62269 in Saint Clair County. The practice phone is (618) 257-5607.

  • Memorial Hospital - Shiloh
    1404 Cross St, O'Fallon, IL 62269 · Saint Clair CountyPhone(618) 257-5607

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Peter John Oppelt is affiliated with 9 sites of care and 2 medical groups

Dr. Oppelt's primary practice is Memorial Hospital - Shiloh in O'Fallon, Illinois. Dr. Oppelt is also affiliated with Barnes-Jewish Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Oppelt to 4 more hospitals, 2 group practices and clinics, 1 hospice and 1 medical group, each named with a free account.

See all 11 affiliations for Dr. Oppelt

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Peter John Oppelt's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Oppelt practices, 8 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Memorial Hospital - ShilohAvailable with a free account
+8 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Oppelt practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Peter John Oppelt is one of 153 medical oncologists in Illinois

Medical oncology is Dr. Oppelt's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Oppelt is licensed in Missouri.

Specialties and state licenses

  • Medical oncology, MissouriPrimaryLicense 2015014057 · taxonomy 207RX0202X

Medical oncologists near Dr. Oppelt

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

153medical oncologists in Illinois
3medical oncologists in O'Fallon

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Peter John Oppelt billed Medicare for 48,339 services in 2024

CMS data shows 48,339 Medicare services from Dr. Oppelt across 48 procedure codes in 2024, for 629 Medicare patients. Medicare paid $1,154,417 for them.

Medicare services, 202448,339
Medicare patients629
Paid by Medicare$1.2M
Procedure codes48

Dr. Oppelt's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 157,4842024: 44,52872%
Tests and treatments
2023: 3,3782024: 1,50655%
Other services
2023: 12,5252024: 1,48388%
Office and hospital visits
2023: 8512024: 71316%
Surgery
2023: 2432024: 10955%

Where Dr. Oppelt's Medicare services took place, 2024

  • In an office48,311100%
  • In a facility280%

Dr. Oppelt compared with the Illinois median for medical oncologists, 2024

  • Dr. Oppelt
  • Illinois median
Medicare services
48,339vs 67172.0 times
Medicare patients
629vs 2302.7 times
Part D claims
1,783vs 3455.2 times

Medians across 140 medical oncologists in Illinois with Dmand AI profiles that report each measure.

Dr. Oppelt's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Oppelt

Need commercial claims for Dr. Oppelt?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Oppelt and other medical oncologists in Illinois.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Peter John Oppelt treated 629 Medicare patients in 2024, average age 73

CMS counts 629 Medicare patients who saw Dr. Oppelt in 2024. The largest group is 65 to 74, with 301 patients. 74% of them have high blood pressure, and 70% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Oppelt's median patient age at 73, with 27% women.

Medicare patients, 2024629
Average age73
Average risk score2.73
Also on Medicaid10%

Dr. Oppelt's Medicare patients by age, 2024

Dr. Oppelt's Medicare patients by sex, 2024

  • Women26442%
  • Men36558%

Chronic conditions among Dr. Oppelt's Medicare patients, 2024

  1. High blood pressure74%
  2. High cholesterol70%
  3. Cancer45%
  4. Arthritis43%
  5. Ischemic heart disease35%
  6. Anxiety31%
  7. Chronic kidney disease30%
  8. Diabetes29%

Share of Medicare patients with each condition. A patient can have several.

Dr. Oppelt's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 73

Patient panel by sex, all payers

  • Women27%
  • Men73%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Peter John Oppelt wrote 2,073 Medicare Part D claims in 2024

In 2024, Dr. Oppelt wrote 2,073 Medicare Part D claims for 289 patients. 83% of them were for generic drugs. CMS names the drug for 1,783 of them, across 35 drugs with 11 or more claims each, at $1,806,944 in total drug cost. In 2023, CMS named 1,603 claims across 37 drugs.

Part D claims, 20242,073
Drugs named by CMS35
Total drug cost$1.8M
Part D patients289

Dr. Oppelt's Part D claims by kind of drug, 2024

  • Generic1,717 claims83%
  • Brand-name356 claims17%

Dr. Oppelt's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Oppelt's Part D claims, 2024

  • Opioids18%371 of 2,073 claims
  • Antibiotics4%93 of 2,073 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,6032024: 1,78311%

Drugs named by CMS: 35 in 2024, 37 in 2023.

See all prescribing by Dr. Oppelt

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Peter John Oppelt scored 88 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Oppelt for performance year 2024, reported as part of a group. Dr. Oppelt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Oppelt as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Oppelt's MIPS scores, performance year 2024

  • 88of 100Final score
  • 76.1of 100Quality
  • 99of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 76of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Oppelt by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Peter John Oppelt has 49 publications on record

Dmand AI links 49 papers to Dr. Oppelt, published from 2017 to 2025. 2019 was the busiest year, with 8. The most frequent topics are Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck and Antineoplastic Combined Chemotherapy Protocols. Dr. Oppelt has published most often in Clin Cancer Res. Dr. Oppelt's most frequent co-authors are Wade Larry Thorstad, MD, Hiram Alberto Gay, MD and Ryan Scott Jackson, MD.

Papers49
Years published2017 to 2025

Dr. Oppelt's papers by year, 2017 to 2025

Topics Dr. Oppelt writes about most

  • Head and Neck Neoplasms
  • Squamous Cell Carcinoma of Head and Neck
  • Antineoplastic Combined Chemotherapy Protocols
  • Papillomavirus Infections
  • Antineoplastic Agents
  • Carcinoma, Squamous Cell
  • Chemoradiotherapy
  • Cisplatin

Dr. Oppelt's most frequent co-authors

Recent publications by Dr. Oppelt

See all 49 publications and co-authors

See who Dr. Oppelt researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Oppelt works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Peter John Oppelt has worked on 10 clinical trials

Dmand AI links Dr. Oppelt to 10 clinical trials, 8 of them phase 2 studies. 6 are still active or recruiting. Conditions studied include Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell and Carcinoma, Bronchogenic. Washington University School of Medicine sponsors the most, 10.

Clinical trials with Dr. Oppelt by phase

  1. NonePhase 1: no trials
  2. 2Phase 1/2: 2 trials
  3. 8Phase 2: 8 trials
  4. NonePhase 3: no trials
  5. NonePhase 4: no trials

Conditions in Dr. Oppelt's trials

  • Squamous Cell Carcinoma of Head and Neck
  • Carcinoma, Squamous Cell
  • Carcinoma, Bronchogenic
  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma, Renal Cell

Investigators on the most trials with Dr. Oppelt

Recent clinical trials with Dr. Oppelt

See all 10 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Peter John Oppelt received $61,491 in industry payments from 2016 to 2025

CMS Open Payments shows 89 general payments to Dr. Oppelt from 13 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 75% of the total. Bristol-Myers Squibb Company paid the most, $35,668. It also lists 3 research payments totaling $4,080 in 2020.

General payments to Dr. Oppelt by program year, 2016 to 2025

General payments to Dr. Oppelt by kind, 2016 to 2025

$61.5Kin total
  • Speaker and faculty fees$45,88475%
  • Consulting fees$7,12012%
  • Travel and lodging$5,8339%
  • Food and beverage$2,1724%
  • Other$4831%

Companies that paid Dr. Oppelt the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Oppelt

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Peter John Oppelt graduated from University of Missouri, Columbia School of Medicine

Dr. Oppelt graduated from University of Missouri, Columbia School of Medicine in 2008.

  1. Medical schoolUniversity of Missouri, Columbia School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Peter John Oppelt's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Peter John Oppelt

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Peter John Oppelt's NPI number?

Dr. Peter John Oppelt's NPI number is 1639332968. It was assigned on July 7, 2008, and it is active in the NPI Registry.

What kind of doctor is Dr. Peter John Oppelt?

Dr. Peter John Oppelt is a medical oncologist in O'Fallon, Illinois. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Peter John Oppelt practice?

Dr. Oppelt practices at 1404 Cross St, O'Fallon, IL 62269. Dr. Oppelt's primary practice is Memorial Hospital - Shiloh in O'Fallon, Illinois. Dmand AI also links Dr. Oppelt to 4 hospitals, 2 group practices and clinics, 1 hospice and 1 medical group.

What is Dr. Peter John Oppelt's office phone number?

The practice phone on file for Dr. Oppelt is (618) 257-5607.

What is Dr. Peter John Oppelt's medical license number?

Dr. Oppelt holds Missouri license 2015014057.

Which hospitals is Dr. Peter John Oppelt affiliated with?

Dr. Oppelt is affiliated with Barnes-Jewish Hospital. Dmand AI links Dr. Oppelt to 4 more hospitals.

What medical group is Dr. Peter John Oppelt part of?

Dr. Oppelt is linked to WashU Medicine Psychiatry. Dmand AI links Dr. Oppelt to 1 more medical group.

Does Dr. Peter John Oppelt accept Medicare?

Yes. CMS data shows Dr. Oppelt billed Medicare for 48,339 services in 2024, and Dr. Oppelt accepts Medicare assignment.

Does Dr. Peter John Oppelt offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Oppelt as offering telehealth services.

What is Dr. Peter John Oppelt's MIPS score?

Dr. Oppelt's MIPS final score for performance year 2024 is 88 out of 100, reported as part of a group.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Peter John Oppelt see?

CMS counts 629 Medicare patients who saw Dr. Oppelt in 2024, with an average age of 73.

What services does Dr. Peter John Oppelt bill to Medicare?

In 2024, Dr. Oppelt's most billed Medicare services were injected or infused drug (J9299), injected or infused drug (J9271) and injected or infused drug (J1453).

Where did Dr. Peter John Oppelt go to medical school?

Dr. Oppelt graduated from University of Missouri, Columbia School of Medicine in 2008.

What drugs does Dr. Peter John Oppelt prescribe most?

In 2024 Medicare Part D data, Dr. Oppelt's most prescribed drugs by claims were Prednisone, Oxycodone HCl and Levothyroxine Sodium.

Has Dr. Peter John Oppelt received payments from drug or device companies?

CMS Open Payments shows $61,491 in general payments to Dr. Oppelt from 13 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.

How long has Dr. Peter John Oppelt been practicing?

Dr. Oppelt graduated from medical school in 2008, 18 years ago.

Does Dr. Peter John Oppelt do research?

Dmand AI links 49 publications to Dr. Oppelt, published from 2017 to 2025. Dr. Oppelt has worked on 10 clinical trials.

Who does Dr. Peter John Oppelt publish with?

Dr. Oppelt's most frequent co-authors are Wade Larry Thorstad, MD (24 shared papers), Hiram Alberto Gay, MD (19 shared papers) and Ryan Scott Jackson, MD (19 shared papers).

Selling to medical oncology practices?

See medical oncologists in Illinois by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)